Platelet parameters and platelet toll-like receptor 4 (TLR4) expression in patients with sepsis, and the effect of a joint treatment-plan integrating traditional Chinese and western medicine: A clinical study

Chinese Critical Care Medicine

Volumn 23, Issue 10, 2011, Pages 616-620

  Wang, Bing ^a   Wang, Yong Qiang ^a   Cao, Shu Hua ^a   Liang, Yong ^a  

^a Tianjin the First Center Hospital   (China)

Author keywords

Glycoprotein II b III a; Liang Ge San; Sepsis; Soluble CD40 ligand; Thrombocytopenia; Toll like receptor 4

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD40 LIGAND; CREATINE; HERBACEOUS AGENT; LIANG GE SAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; APACHE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; PROTEIN EXPRESSION; SEPSIS; THERAPY EFFECT; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TREATMENT PLANNING; WESTERN MEDICINE;

ADULT; AGED; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLATELET COUNT; PROSPECTIVE STUDIES; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 81855203389     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2011.10.014     Document Type: Article

References (18)

1. Levi M. Löwenberg EC. Thrombocytopenia in critically ill patients. Semin Thromb Hemost,2008,34:417-424.
2. Hui P, Cook DJ, Lim W, et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest,2011,139:271-278.
3. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med,2003,29:530-538. (Pubitemid 36523666)
4. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med,2004,32:858-873. (Pubitemid 38344143)
5. Strauss R, Wehler M, Mehler K, et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med,2002,30:1765-1771.
6. Verstraete M. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development. Circulation,2000,101:E76-E80.
7. Henn V, Steinbach S, Büchner K, et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood,2001,98:1047-1054.
8. Goldstein DR. Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol,2004,16:538-544. (Pubitemid 39165878)
9. Schilling JD, Mulvey MA, Vincent CD, et al. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide- dependent mechanism. J Immunol,2001,166:1148-1155. (Pubitemid 32060274)
10. Cognasse F, Hamzeh H, Chavarin P, et al. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol,2005,83:196-198. (Pubitemid 40469328)
11. McGuire K, Jones M, Werling D, et al. Radiation hybrid mapping of all 10 characterized bovine Toll-like receptors. Anim Genet,2006,37:47-50. (Pubitemid 43381852)